Tooth showdown: which pulp capping material wins?
NCT ID NCT07147036
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested two materials, Biodentine and Calcium Hydroxide, placed under fillings to protect the tooth nerve in 76 adults with reversible pulpitis. Over 12 weeks, researchers checked pain, X-ray changes, and nerve responses to see which material better kept the tooth alive and healthy. The goal is to find a more effective way to treat deep cavities without needing a root canal.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Biodentine and Calcium Hydroxide
What this could lead to
If successful, this could show that Biodentine is a better material for preserving tooth vitality and reducing pain after cavity treatment.
What could go wrong
This is a small, completed study with only 76 participants, so results may not apply to everyone. The follow-up is short (12 weeks), so long-term success is unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REVERSIBLE PULPITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HITEC-IMS Taxila
Rawalpindi, Punjab Province, 47080, Pakistan